Key 2024 wins: Sold Zequanox Gen 1, advanced Gen 2, progressed Piscamycin & herbicides, met shrimp grant goals, and expanded facilities.

We’re hitting milestones: Gen 1 Zequanox sold, Gen 2 advancing, Piscamycin on track for 4Q 2025, and herbicide candidates in progress.

In this issue: Burrowing shrimp project trip, R&D updates, ISC team growth, and Senior Scientist Namrata's thesis defense in Finland.